Summit Global Investments’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-4,421
| Closed | -$1.29M | – | 537 |
|
|
2026
Q1 | $1.29M | Sell |
4,421
-5,190
| -54% | -$1.71M | 0.08% | 139 |
|
|
2025
Q4 | $3.37M | Sell |
9,611
-4,644
| -33% | -$1.57M | 0.2% | 58 |
|
|
2025
Q3 | $4.61M | Sell |
14,255
-926
| -6% | -$288K | 0.27% | 59 |
|
|
2025
Q2 | $5.91M | Sell |
15,181
-5,383
| -26% | -$2.17M | 0.35% | 53 |
|
|
2025
Q1 | $8.95M | Sell |
20,564
-4,408
| -18% | -$1.77M | 0.65% | 26 |
|
|
2024
Q4 | $9.21M | Sell |
24,972
-2,544
| -9% | -$1.06M | 0.58% | 41 |
|
|
2024
Q3 | $14.3M | Buy |
27,516
+505
| +2% | +$270K | 0.91% | 20 |
|
|
2024
Q2 | $14.6M | Sell |
27,011
-5,737
| -18% | -$3.03M | 0.99% | 20 |
|
|
2024
Q1 | $17M | Sell |
32,748
-8,476
| -21% | -$4.22M | 1.26% | 12 |
|
|
2023
Q4 | $19.4M | Sell |
41,224
-3,919
| -9% | -$1.81M | 1.27% | 14 |
|
|
2023
Q3 | $19.7M | Buy |
45,143
+29,422
| +187% | +$13.3M | 1.31% | 11 |
|
|
2023
Q2 | $6.99M | Buy |
15,721
+12,765
| +432% | +$5.89M | 0.46% | 57 |
|
|
2023
Q1 | $1.36M | Buy |
+2,956
| New | +$1.41M | 0.11% | 184 |
|
|
2020
Q4 | – | Sell |
-11,973
| Closed | -$3.22M | – | 261 |
|
|
2020
Q3 | $3.22M | Sell |
11,973
-938
| -7% | -$252K | 0.33% | 56 |
|
|
2020
Q2 | $3.4M | Buy |
12,911
+11,998
| +1,314% | +$3.2M | 0.39% | 48 |
|
|
2020
Q1 | $207K | Sell |
913
-31
| -3% | -$8.45K | 0.03% | 210 |
|
|
2019
Q4 | $285K | Sell |
944
-11
| -1% | -$3.03K | 0.03% | 259 |
|
|
2019
Q3 | $229K | Sell |
955
-47
| -5% | -$12.9K | 0.03% | 265 |
|
|
2019
Q2 | $283K | Sell |
1,002
-8
| -0.8% | -$2.19K | 0.04% | 270 |
|
|
2019
Q1 | $290K | Buy |
1,010
+7
| +0.7% | +$2.02K | 0.04% | 265 |
|
|
2018
Q4 | $263K | Sell |
1,003
-201
| -17% | -$55.3K | 0.04% | 242 |
|
|
2018
Q3 | $330K | Sell |
1,204
-185
| -13% | -$48K | 0.04% | 240 |
|
|
2018
Q2 | $331K | Sell |
1,389
-26,959
| -95% | -$6.24M | 0.05% | 241 |
|
|
2018
Q1 | $6.23M | Sell |
28,348
-21,956
| -44% | -$5.16M | 0.99% | 34 |
|
|
2017
Q4 | $11.3M | Sell |
50,304
-1,624
| -3% | -$346K | 1.75% | 14 |
|
|
2017
Q3 | $9.86M | Buy |
51,928
+27,687
| +114% | +$5.27M | 1.54% | 27 |
|
|
2017
Q2 | $4.56M | Buy |
24,241
+9,541
| +65% | +$1.71M | 1.36% | 25 |
|
|
2017
Q1 | $2.43M | Buy |
14,700
+1,464
| +11% | +$233K | 0.79% | 40 |
|
|
2016
Q4 | $1.9M | Buy |
+13,236
| New | +$1.77M | 0.69% | 45 |
|
Other funds holding ELV
Summit Global Investments's ELV Position: Q2 2026 in Review
Summit Global Investments sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 4,421 shares — an estimated $1.29M sold.
Summit Global Investments first reported a position in ELV in Q4 2016 and held it in 29 quarters. The position peaked at $19.7M in Q3 2023. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Summit Global Investments reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
- Summit Global Investments sold 4,421 Elevance Health shares in Q2 2026, an estimated $1.29M.
- Summit Global Investments first reported a position in Elevance Health in Q4 2016 and held it in 29 quarters.
- Summit Global Investments's Elevance Health position peaked at $19.7M in Q3 2023.
- 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.